Join our growing community to challenge mainstream media bias and fix the news
Lilly to continue to work on coronavirus antibody treatment despite poor results

Lilly to continue to work on coronavirus antibody treatment despite poor results

Eli Lilly CEO Dave Ricks told CNBC on Tuesday that he believes the company’s coronavirus antibody treatment will still be beneficial to Covid-19 patients, despite the recent end to a study of the drug in a hospital setting. The company agreed that the study showed the drug was ’unlikely’ to be useful in later stages of the disease but will try it for less ill patients.

Skeptic
Skeptic
Top in Business